M2 buys NZ's Call Plus
M2's purchase of New Zealand's number three broadband and fixed voice provider ticks a lot of boxes and the price looks cheap.
Ramsay offers poor value
Australia's largest hospital operator has barely put a foot wrong in more than a decade - but its share price leaves no room for error in the next.
Brickworks, Soul Patts: Interim update
An unprecedented construction boom and the success of TPG Telecom have helped lift the share prices of Soul Patts and Brickworks. What now?
IRESS targets UK wealth
IRESS is looking for growth in the UK wealth management market, but it will have to deal with the regulatory threat to its core adviser market.
Gentrack: Like Hansen, only cheaper
Billing software provider Hansen has returned 54% in five months. If you missed the boat, you may soon get a second chance.
Don't gamble on Crown Subordinated Notes II
As with Crown's casino games, the terms of Notes II are heavily weighted in the company's favour.
GBST's platform for growth
We've missed out on this software provider's gains so far, but we think there should be plenty more to come.
Mining services update HY2015
Revenues have fallen, assets have been written down and share prices have tumbled; mining services remains a dangerous part of the market. But there remains a case for dipping in.
A-REITs expensive on almost every measure
There are no bargains here but if you do own any of the 24 stocks covered in this review, you might want to start thinking about selling them.
GBST's platform for growth
We've missed out on this software provider's gains so far, but we think there should be plenty more to come.
ARB Corp's sales rebound
Sales to the big car companies grew strongly, but higher costs are squeezing margins.
CSL: Australia's best resource stock-Part 2
When you combine a low-cost resource company with non-commodity products, there's plenty of money to be made.
Northern Star: take profits
After a stunning ride that has seen this gold miner's share price triple, it's time to take profits.
CSL: Australia's best resource stock
Our tour of CSL's US facilities offered plenty of surprises. From the Deep South, CSL looks a lot like Saudi Arabia.
Keep heart with ResMed
Excitement is building over the benefits of ventilation therapy for heart failure patients, and it's encouragement enough for us to raise our price guide.
Sirtex's trial disappoints
Sirtex shares plunged as the company announced poor results from a medical trial.
Keep heart with ResMed
Excitement is building over the benefits of ventilation therapy for heart failure patients, and it's encouragement enough for us to raise our price guide.
Reflections of a gold investor
In aggregate, our gold mini portfolio has neither gained nor fallen much. Yet this hides extraordinary moves in both directions. Gaurav Sodhi updates on the progress of the portfolio.
TPG makes bid for iiNet
TPG has made a bid for its west coast rival, to cement its position as the number two broadband provider to Telstra.
Fleetwood: A better buy
A lower share price and improvements to the investment case make Fleetwood a better buy.
Woolworths will need tougher action
Flat sales over the Christmas period have forced Woolworths into a strategy rethink and a profit downgrade.
Computershare downgraded to Hold
This share registry company has bounced 15% in a month, putting it well above our Buy price. We're downgrading to Hold.
Doctors orders: Monash vs Vision
Vision Eye Institute's margins were crushed when its doctors started to abandon ship. Could it happen to Monash IVF?
Call 1300 880 160
Start a chat
Schedule a call
